|
|
|
Insider
Information: |
Vaishnaw Akshay |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
45,729 |
|
Indirect Shares
|
515 |
|
|
Direct
Value |
$6,410,556 |
|
|
Indirect Value
|
$140,672 |
|
|
Total
Shares |
46,244 |
|
|
Total
Value |
$6,551,228 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-26.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2024-06-27 |
22,955 |
2024-06-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-01-24 |
4 |
AS |
$84.57 |
$676,589 |
D/D |
(7,890) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-02-21 |
4 |
D |
$90.10 |
$235,611 |
I/I |
(2,615) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-03-18 |
4 |
AS |
$73.34 |
$2,423,223 |
D/D |
(32,769) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-06-17 |
4 |
AS |
$69.33 |
$741,798 |
D/D |
(10,625) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-09-16 |
4 |
AS |
$71.34 |
$765,463 |
D/D |
(10,625) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-12-16 |
4 |
AS |
$91.47 |
$994,588 |
D/D |
(10,626) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-03-17 |
4 |
AS |
$115.29 |
$1,022,568 |
D/D |
(8,750) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-06-16 |
4 |
AS |
$128.10 |
$1,127,239 |
D/D |
(8,750) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2018-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
28 |
366 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2018-07-10 |
4 |
A |
$0.00 |
$0 |
I/I |
29 |
395 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2018-10-18 |
4 |
A |
$0.00 |
$0 |
I/I |
21 |
416 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2019-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
51 |
467 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
|
2019-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
48 |
515 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, Clinical ResearchOfficer |
|
2009-03-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
799 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-11-25 |
4 |
OE |
$16.43 |
$99,750 |
D/D |
5,750 |
5,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2016-11-30 |
4 |
AS |
$44.34 |
$1,311,998 |
D/D |
(29,165) |
5,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-01-23 |
4 |
D |
$89.49 |
$420,424 |
D/D |
(4,698) |
7,890 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-03-17 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
|
2015-06-16 |
4 |
OE |
$7.10 |
$75,875 |
D/D |
8,750 |
8,750 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2016-12-30 |
4 |
D |
$37.44 |
$187,200 |
D/D |
(5,000) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
SVP, R&D |
|
2017-05-15 |
4 |
AS |
$65.00 |
$2,843,750 |
D/D |
(43,750) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
|
2017-05-23 |
4 |
AS |
$75.00 |
$825,000 |
D/D |
(11,000) |
10,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-06-17 |
4 |
OE |
$7.10 |
$93,013 |
D/D |
10,625 |
10,625 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-09-16 |
4 |
OE |
$7.10 |
$93,013 |
D/D |
10,625 |
10,625 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
|
2014-12-16 |
4 |
OE |
$7.10 |
$93,022 |
D/D |
10,626 |
10,626 |
0 |
- |
|
97 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|